Monocrystalline Silicon vs Silica: How Silicon Wafers Are Made from Quartz

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Silicon Oxide? SiO vs SiO₂ Differences and Applications Explained
  • Keywords: hydrophobic fumed silica
  • Published: 2026-11-20 10:56:45
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
38. Kheirkhah S., Abedi M., Zare F., Salmanpour M., Abolmaali S.S., Tamaddon A.M. Surface engineered palmitoyl-mesoporous silica nanoparticles with supported lipid bilayer coatings for high-capacity loading and prolonged release of dexamethasone: A factorial design approach. J. Drug Deliv. Sci. Technol. 2022;78:103943. doi: 10.1016/j.jddst.2022.103943. [ DOI ] [ Google Scholar ]

Wood Coating Matting Agent: How to Achieve a Low-Gloss, Clear Finish

Silica Industry Outlook 2026: Challenges, Opportunities and Growth Areas
Quartz Powder Supplier: Grades, Purity and How to Evaluate Suppliers
Another study concentrated on repaglinide, an oral antidiabetic drug [ 84 ] from the BCS class II, with poor solubility but high permeability. In addition, it has a significant first-pass effect, and the combination of these two features results in low oral bioavailability. The researchers prepared a repaglinide solid dispersion employing mesoporous silica to enhance solubility and drug release. Based on in vitro tests, the repaglinide-MSN complex exhibited significant improvement, compared to the pure drug [ 84 ]. Then this solid dispersion was effectively incorporated into a medicated chewing gum. This buccal administration causes the drug to bypass first-pass metabolism, further boosting oral bioavailability. Based on their clinical investigations, the researchers proved that this formulation showed an increased antidiabetic activity compared to the marketed product by measuring blood glucose levels. In summary, this solid dispersion chewing gum formulation can be a promising perspective in antidiabetic therapy [ 84 ].
Nouryon Levasil: Colloidal Silica Product Range and Applications
One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].
Silica for Sealants: Grades, Functions and Formulation Guide
20. Šoltys M., Zůza D., Boleslavská T., Akhlasová S.M., Balouch M., Kovačík P., Beránek J., Škalko-Basnet N., Flaten G.E., Štěpánek F. Drug loading to mesoporous silica carriers by solvent evaporation: A comparative study of amorphization ability and release kinetics. Int. J. Pharm. 2021;607:120982. doi: 10.1016/j.ijpharm.2021.120982. [ DOI ] [ PubMed ] [ Google Scholar ]

Silica Storage Conditions: How to Store Silica to Prevent Moisture and Caking

What is silica (SiO₂)?

synthetic amorphous silica Experiments with different dosage forms and their potential use in treatment.

What is the difference between fumed silica and precipitated silica?

kaolin

What drives silica raw material prices?

silica dielectric constant Insects cannot construct up a resistance to DE like they can a chemical pesticide

Cite this article: Silica Raw Materials News. "HD Silica Explained: Highly Dispersible Silica Specs, Benefits and Tire Applications ." Published 2026-11-20 10:56:45. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.